Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017

Radiology

Volumn 284, Issue 1, 2017, Pages 228-243

  MacMahon, Heber ^a   Naidich, David P ^b   Goo, Jin Mo ^c   Lee, Kyung Soo ^d   Leung, Ann N C ^e   Mayo, John R ^f   Mehta, Atul C ^g   Ohno, Yoshiharu ^h   Powell, Charles A ⁱ   Prokop, Mathias ^j   Rubin, Geoffrey D ^k   Schaefer Prokop, Cornelia M ^l   Travis, William D ^m   Van Schil, Paul E ⁿ   Bankier, Alexander A ^o  

^a UNIVERSITY OF CHICAGO   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c Seoul National University College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g LERNER RESEARCH INSTITUTE   (United States)

^h KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l MEANDER MEDICAL CENTER   (Netherlands)

^m MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁿ ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^o BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

AGE; APICAL SCARRING; CONSENSUS; EMPHYSEMA; FAMILY HISTORY; FOLLOW UP; GENDER; HIGH RISK PATIENT; HUMAN; INCIDENTAL FINDING; INVASIVE PROCEDURE; LOW RISK PATIENT; LUNG CANCER; LUNG FIBROSIS; LUNG NODULE; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATHOLOGIST; PATIENT; PATIENT CARE; PATIENT PREFERENCE; PERIFISSURAL NODULE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONOLOGIST; RACE; RADIOLOGIST; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCAR; SOLID MALIGNANT NEOPLASM; SURGEON; THORACIC RADIOLOGIST; THORAX RADIOGRAPHY; TOBACCO; X-RAY COMPUTED TOMOGRAPHY; ADULT; AGED; DIAGNOSTIC IMAGING; LUNG TUMOR; MIDDLE AGED; MULTIPLE PULMONARY NODULES; PATHOLOGY; STANDARDS;

ADULT; AGED; HUMANS; INCIDENTAL FINDINGS; LUNG NEOPLASMS; MIDDLE AGED; MULTIPLE PULMONARY NODULES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85019903375     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2017161659     Document Type: Review

References (97)

1. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237(2):395-400.
2. Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266(1):304-317.
3. Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA. What do you mean, a spot? a qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest 2013;143(3):672-677.
4. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409.
5. Farooqi AO, Cham M, Zhang L, et al. Lung cancer associated with cystic airspaces. AJR Am J Roentgenol 2012;199(4):781-786.
6. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15(12):1332-1341.
7. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369(10):910-919.
8. Kazerooni EA, Armstrong MR, Amorosa JK, et al. ACR CT Accreditation Program and the Lung Cancer Screening Program Designation. J Am Coll Radiol 2016;13(2 Suppl):R30-R34.
9. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006;129(1):174-181.
10. Webb WR. Radiologic evaluation of the solitary pulmonary nodule. AJR Am J Roentgenol 1990;154(4):701-708.
11. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL. Solitary pulmonary nodules. I. Morphologic evaluation for differentiation of benign and malignant lesions. Radio-Graphics 2000;20(1):43-58.
12. Gaerte SC, Meyer CA, Winer-Muram HT, Tarver RD, Conces DJ Jr. Fat-containing lesions of the chest. RadioGraphics 2002;22(Spec No):S61-S78.
13. Bankier AA, Tack D. Dose reduction strategies for thoracic multidetector computed tomography: background, current issues, and recommendations. J Thorac Imaging 2010;25(4):278-288.
14. Gelbman BD, Cham MD, Kim W, et al. Radiographic and clinical characterization of false negative results from CT-guided needle biopsies of lung nodules. J Thorac Oncol 2012;7(5):815-820.
15. Zhang L, Yankelevitz DF, Carter D, Henschke CI, Yip R, Reeves AP. Internal growth of nonsolid lung nodules: radiologic-pathologic correlation. Radiology 2012;263(1):279-286.
16. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369(3):245-254.
17. Hein PA, Romano VC, Rogalla P, et al. Linear and volume measurements of pulmonary nodules at different CT dose levels: intrascan and interscan analysis. Rofo 2009;181(1):24-31.
18. Ashraf H, de Hoop B, Shaker SB, et al. Lung nodule volumetry: segmentation algorithms within the same software package cannot be used interchangeably. Eur Radiol 2010;20(8):1878-1885.
19. de Hoop B, Gietema H, van Ginneken B, Zanen P, Groenewegen G, Prokop M. A comparison of six software packages for evaluation of solid lung nodules using semiautomated volumetry: what is the minimum increase in size to detect growth in repeated CT examinations. Eur Radiol 2009;19(4):800-808.
20. Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ, Im JG. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radio-Graphics 2007;27(2):391-408.
21. Samet JM, Avila-Tang E, Boffetta P, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009;15(18):5626-5645.
22. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42(6):1659-1667.
23. Zhao B, James LP, Moskowitz CS, et al. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology 2009;252(1):263-272.
24. Shin KE, Lee KS, Yi CA, Chung MJ, Shin MH, Choi YH. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry. Respirology 2014;19(6):921-928.
25. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidencebased clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):108S-130S.
26. Soardi GA, Perandini S, Motton M, Montemezzi S. Assessing probability of malignancy in solid solitary pulmonary nodules with a new Bayesian calculator: improving diagnostic accuracy by means of expanded and updated features. Eur Radiol 2015;25(1):155-162.
27. Goodsitt MM, Chan HP, Way TW, Schipper MJ, Larson SC, Christodoulou EG. Quantitative CT of lung nodules: dependence of calibration on patient body size, anatomic region, and calibration nodule size for single-and dual-energy techniques. Med Phys 2009;36(7):3107-3121.
28. Herold CJ, Bankier AA, Fleischmann D. Lung metastases. Eur Radiol 1996;6(5):596-606.
29. Peters R, Heuvelmans MA, Vliegenthart R, Van Ooijen PM, De Bock GH, Oudkerk M. Prevalence of pulmonary multi-nodularity in CT lung cancer screening and lung cancer probability [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2015; 111.
30. Kakinuma R, Muramatsu Y, Kusumoto M, et al. Solitary pure ground-glass nodules 5 mm or smaller: frequency of growth. Radiology 2015;276(3):873-882.
31. Aoki T. Growth of pure ground-glass lung nodule detected at computed tomography. J Thorac Dis 2015;7(9):E326-E328.
32. Kobayashi Y, Fukui T, Ito S, et al. How long should small lung lesions of groundglass opacity be followed? J Thorac Oncol 2013;8(3):309-314.
33. Lim HJ, Ahn S, Lee KS, et al. Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013;144(4):1291-1299.
34. Yankelevitz DF, Yip R, Smith JP, et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 2015;277(2):555-564.
35. Hwang IP, Park CM, Park SJ, et al. Persistent pure ground-glass nodules larger than 5 mm: differentiation of invasive pulmonary adenocarcinomas from preinvasive lesions or minimally invasive adenocarcinomas using texture analysis. Invest Radiol 2015;50(11):798-804.
36. Lee HY, Choi YL, Lee KS, et al. Pure groundglass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol 2014;202(3):W224-W233.
37. Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013;268(1):265-273.
38. Silva M, Bankier AA, Centra F, et al. Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on CT: relation to clinical metrics. Diagn Interv Radiol 2015;21(5):385-390.
39. Jin X, Zhao SH, Gao J, et al. CT characteristics and pathological implications of early stage (T1N0M0) lung adenocarcinoma with pure ground-glass opacity. Eur Radiol 2015;25(9):2532-2540.
40. Xiang W, Xing Y, Jiang S, et al. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography. Cancer Imaging 2014;14(1):33.
41. Choi WS, Park CM, Song YS, Lee SM, Wi JY, Goo JM. Transient subsolid nodules in patients with extrapulmonary malignancies: their frequency and differential features. Acta Radiol 2015;56(4):428-437.
42. Lee JH, Park CM, Lee SM, Kim H, Mc-Adams HP, Goo JM. Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: their natural course and predictors of interval growth. Eur Radiol 2016;26(6):1529-1537.
43. Cohen JG, Reymond E, Lederlin M, et al. Differentiating pre- and minimally invasive from invasive adenocarcinoma using CTfeatures in persistent pulmonary part-solid nodules in Caucasian patients. Eur J Radiol 2015;84(4):738-744.
44. Lee SM, Park CM, Goo JM, et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010;255(1):242-251.
45. Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular groundglass opacity at thin-section CT: histopathologic comparisons. Radiology 2007;245(1): 267-275.
46. Saito H, Yamada K, Hamanaka N, et al. Initial findings and progression of lung adenocarcinoma on serial computed tomography scans. J Comput Assist Tomogr 2009;33(1):42-48.
47. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologicpathologic correlation and its prognostic impact. Ann Thorac Surg 2006;81(2):413-419.
48. Hwang EJ, Park CM, Ryu Y, et al. Pulmonary adenocarcinomas appearing as partsolid ground-glass nodules: is measuring solid component size a better prognostic indicator? Eur Radiol 2015;25(2):558-567.
49. Liao JH, Amin VB, Kadoch MA, Beasley MB, Jacobi AH. Subsolid pulmonary nodules: CT-pathologic correlation using the 2011 IASLC/ATS/ERS classification. Clin Imaging 2015;39(3):344-351.
50. Matsuguma H, Mori K, Nakahara R, et al. Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013;143(2):436-443.
51. Tamura M, Shimizu Y, Yamamoto T, Yoshikawa J, Hashizume Y. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on highresolution images for the possibility of future change. J Thorac Oncol 2014;9(4):469-472.
52. Lee KH, Goo JM, Park SJ, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J Thorac Oncol 2014;9(1):74-82.
53. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355(17):1763-1771. [Published corrections appear in N Engl J Med 2008;358(17):1875 and N Engl J Med 2008;359(8):877.]
54. Saji H, Matsubayashi J, Akata S, et al. Correlation between whole tumor size and solid component size on high-resolution computed tomography in the prediction of the degree of pathologic malignancy and the prognostic outcome in primary lung adenocarcinoma. Acta Radiol 2015;56(10):1187-1195.
55. International Agency for Research on Cancer. Minimally invasive adenocarcinoma in WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: International Agency for Research on Cancer, 2015.
56. Ujiie H, Kadota K, Chaft JE, et al. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival. J Clin Oncol 2015;33(26):2877-2884.
57. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6(2):244-285.
58. Travis WD, Asamura H, Bankier AA, et al. The IASLC Lung Cancer Staging Project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer. J Thorac Oncol 2016;11(8):244-285.
59. van Riel SJ, Sánchez CI, Bankier AA, et al. Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management. Radiology 2015;277(3):863-871.
60. Matsuguma H, Oki I, Nakahara R, et al. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2013;95(6):1878-1884.
61. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at aaseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. I. Radiology, 2009;250(1):264-272.
62. Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242(2):555-562.
63. Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187(8):848-854.
64. Heuvelmans MA, Oudkerk M, de Bock GH, et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013;23(7):1836-1845.
65. Mehta HJ, Ravenel JG, Shaftman SR, et al. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest 2014;145(3):464-472.
66. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73(876):1252-1259.
67. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178(7):738-744.
68. de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007;132(6):1932-1938.
69. Chiles C, Duan F, Amorosa JK, et al. Sexand gender-linked differences in baseline characteristics of the National Lung Screening Trial [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2015; 111.
70. Kwak N, Park CM, Lee J, et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med 2014;108(3):524-530.
71. Gadgeel SM, Ramalingam S, Cummings G, et al. Lung cancer in patients, 50 years of age: the experience of an academic multidisciplinary program. Chest 1999;115(5):1232-1236.
72. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):5-29.
73. Boiselle PM. Lung nodule consistency and relative risk of future lung cancer diagnosis: does sex matter? [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2015; 111.
74. Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006;354(4):333-342.
75. Kobayashi Y, Sakao Y, Deshpande GA, et al. The association between baseline clinicalradiological characteristics and growth of pulmonary nodules with ground-glass opacity. Lung Cancer 2014;83(1):61-66.
76. Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011;377(9760):139-146.
77. Tamura M, Shimizu Y, Yamamoto T, Yoshikawa J, Hashizume Y. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on highresolution images for the possibility of future change. J Thorac Oncol 2014;9(4):469-472.
78. Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014;511(7511): 543-550.
79. Field RW, Steck DJ, Smith BJ, et al. Residential radon gas exposure and lung cancer: the Iowa Radon Lung Cancer Study. Am J Epidemiol 2000;151(11):1091-1102.
80. Gottlieb LS, Husen LA. Lung cancer among Navajo uranium miners. Chest 1982; 81(4):449-452.
81. Lee PN. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med 2001; 58(3):145-153.
82. Lauterstein D, Hoshino R, Gordon T, Watkins BX, Weitzman M, Zelikoff J. The changing face of tobacco use among United States youth. Curr Drug Abuse Rev 2014;7(1):29-43.
83. Gould MK, Donnington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e93S-e120S.
84. Kim HK, Shin BK, Cho SJ, et al. Transthoracic fine needle aspiration and core biopsy of pulmonary lesions. a study of 296 patients. Acta Cytol 2002;46(6):1061-1068.
85. Kothary N, Lock L, Sze DY, Hofmann LV. Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy. Clin Lung Cancer 2009;10(5):360-363.
86. Tsunezuka Y, Shimizu Y, Tanaka N, Takayanagi T, Kawano M. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size. World J Surg 2007;31(2):314-317.
87. Chu ZG, Yang ZG, Shao H, et al. Small peripheral lung adenocarcinoma: CT and histopathologic characteristics and prognostic implications. Cancer Imaging 2011;11(11):237-246.
88. Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e142S-e165S.
89. Kohno T, Fujimori S, Kishi K, Fujii T. Safe and effective minimally invasive approaches for small ground glass opacity. Ann Thorac Surg 2010;89(6):S2114-S2117.
90. Lynch JE, Zwischenberger JB. Is a smaller resection a smaller operation? Chest 2011;139(3):481-482.
91. Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. J Thorac Cardiovasc Surg 2007;134(4):877-882.
92. Van Schil PE, Asamura H, Rusch VW, et al. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 2012;39(2):478-486.
93. Ost DE, Gould MK. Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med 2012;185(4):363-372.
94. de Hoop B, van Ginneken B, Gietema H, Prokop M. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012;265(2):611-616.
95. Ahn MI, Gleeson TG, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010;254:949-956.
96. Bankoff MS, McEniff NJ, Bhadelia RA, Garcia-Moliner M, Daly BD. Prevalence of pathologically proven intrapulmonary lymph nodes and their appearance on CT. AJR Am J Roentgenol 1996;167:629-630.
97. Gould MK, Tang T, Liu IL, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med 2015;192(10):1208-1214.